More information: Alina Renz et al, Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses, Communications Biology (2025). DOI: 10.1038 ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

Scientists have discovered a stealthy mechanism that cytomegalovirus (CMV)—the leading infectious cause of birth defects in ...

Antiviral drugs often work by preventing the virus from attaching to or entering the host cell, or by obstructing its replication once it’s in there. The drug remdesivir, ...

The expensive medication does little to prevent hospitalisation or death for people who are vaccinated against the virus, a ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

This method accelerates the time-consuming identification and development of antiviral agents that could be crucial in the event of future pandemics. Detecting potential targets for antiviral ...

Renz A. et al, Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses, Communications Biology, 23 Mai 2025, https: ...

"All influenza antiviral drugs exert a selective pressure on viruses, which can result in the emergence of drug-resistant variants," Monto and team explained. Still, ...

Therefore, fast-acting antiviral drugs with broad activity against multiple respiratory coronaviruses and the ability to be rapidly distributed as oral treatments are urgently needed. By creating a ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...